Alex Shlyankevich
Directeur/Membre du Conseil chez Vision Technologies Ltd.
Profil
Alex Shlyankevich has held various director positions in different companies such as NupulseCV, Inc., Felicitex Therapeutics, Inc., Vision Technologies Ltd., and Constant Therapeutics LLC.
Postes actifs de Alex Shlyankevich
| Sociétés | Poste | Début |
|---|---|---|
Vision Technologies Ltd.
 Vision Technologies Ltd. Packaged SoftwareTechnology Services Vision Technologies Ltd. develops software for wearable devices that has the potential to transform the lives of blind and visually impaired. The company was founded by Stanislav Karpenko in June 2014 and is headquartered in London, the United Kingdom. | Directeur/Membre du Conseil | - |
NupulseCV, Inc.
 NupulseCV, Inc. Medical SpecialtiesHealth Technology NupulseCV, Inc. operates as a medical device company that develops technology to treat patients with heart failure. Its device which requires a minimally invasive surgery provides patients an alternative to medical therapy. The firm maintains strategic and financial partnership with heart failure companies around the world. The company was founded in 2010 and is headquartered in Raleigh, NC. | Directeur/Membre du Conseil | 01/03/2016 |
Felicitex Therapeutics, Inc.
 Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Directeur/Membre du Conseil | 01/01/2017 |
| Constant Therapeutics LLC | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
NupulseCV, Inc.
NupulseCV, Inc. Medical SpecialtiesHealth Technology NupulseCV, Inc. operates as a medical device company that develops technology to treat patients with heart failure. Its device which requires a minimally invasive surgery provides patients an alternative to medical therapy. The firm maintains strategic and financial partnership with heart failure companies around the world. The company was founded in 2010 and is headquartered in Raleigh, NC. | Health Technology |
Felicitex Therapeutics, Inc.
Felicitex Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Felicitex Therapeutics, Inc. is a pre-clinical stage oncology drug development company developing therapies against cancer and diabetes. It operates through the Felicitex Business and TraMeta segments. The Felicitex Business segment handles the design and patents of small molecules and related methods to selectively disrupt dormant cancer cells in a manner that is specific to the disease and tissue context. The TarMeta segment built a drug discovery platform for small molecule inhibitors targeting cancer. The company was founded by Maria Vilenchik and Michael Frid on May 4, 2012 and is headquartered in Natick, MA. | Commercial Services |
Vision Technologies Ltd.
Vision Technologies Ltd. Packaged SoftwareTechnology Services Vision Technologies Ltd. develops software for wearable devices that has the potential to transform the lives of blind and visually impaired. The company was founded by Stanislav Karpenko in June 2014 and is headquartered in London, the United Kingdom. | Technology Services |
| Constant Therapeutics LLC |
